Global Speaker Series
Brain, Mitochondria & Metabolism: A Transdiagnostic Dimension
Date: January 23, 2024
Time: 12:00 pm – 1:00 pm EST
Location: Donnelly Centre for Cellular and Biomolecular Research, Red Room (160 College Street
Toronto)
The Medicine by Design Global Speaker Series invites established and emerging international leaders in regenerative medicine to engage with our extraordinary community of researchers and clinicians.
Join speaker Ana Andreazza, Professor in the Departments of Pharmacology & Toxicology and Psychiatry at the University of Toronto, Tier II Canada Research Chair in Molecular Pharmacology of Mood Disorders, and Thomas C. Zachos Chair in Mitochondrial Research.
Hosted by Medicine by Design, in partnership with the McEwen Stem Cell Institute.
Interested in connecting with Ana Andreazza? Please contact info.mbd@utoronto.ca for a 30-minute one-on-one virtual meeting the week of the event, and we will follow up with available timeslots. Spaces are limited!
Dr. Ana Andreazza, a Professor at the University of Toronto in Pharmacology & Toxicology and Psychiatry, holds the Tier II Canada Research Chair in Molecular Pharmacology of Mood Disorders and the Thomas C. Zachos Chair in Mitochondrial Research. She is the Founder and Scientific Director of the Mitochondrial Innovation Initiative, a Senior Fellow of Massey College, and a Member of the Royal Society of Canada College of New Scholars.
Dr. Andreazza’s research focuses on the role of mitochondrial function in health and disease, particularly in neurological and psychiatric disorders, organ transplant and regeneration, and novel therapeutics for mitochondrial health improvement. Notably, her work on mood disorders like bipolar disorder involves identifying dysregulation in mitochondrial genes and utilizing 3D brain organoids for personalized treatments. In organ transplantation, she concentrates on preserving donor organs, especially lungs, and improving transplantation outcomes by studying cell metabolism and mitochondrial health, contributing to better donor-recipient matches and enhancing patient care. Pioneering in mitochondrial transplantation and therapy, she explores the stability, safety, and efficacy of mitochondria transplant for regenerative medicine and chronic diseases.
Dr. Andreazza’s approach integrates cross-disciplinary collaboration, intertwining mitochondrial function with various health aspects. Leading the Mitochondrial Innovation Initiative, she drives advances in mitochondrial biology, fostering knowledge exchange and groundbreaking discoveries for patient and societal benefits.
